The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
For a few years, the second seasonal COVID-19 spike has been accompanied by rising cases of seasonal flu and RSV in what ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Respiratory illnesses like the flu and COVID-19 spread more commonly in the fall and winter months ahead, and doctors in ...
Researchers found that vaccine effectiveness was 80% and 81% against RSV-associated hospitalizations and against RSV-associated critical illness among 28,271 hospitalizations for RSV-like illness ...
Romper on MSN3d
So Your Preschooler Has RSV & You're Worried About Your Newborn. Here's What Pediatricians Suggest.Sure, I’m neurotic, but it wasn’t just that: Infecting a newborn with RSV is a very real risk when they live with a Petri ...
Weekly COVID-19 case numbers reported by the Montana Department of Public Health and Human Services continue to drop.There ...
Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...
Glamour on MSN7d
RSV Symptoms: Here’s How the Virus Shows Up Differently in Babies, Adults, and SeniorsJust like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback